Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,336 | 146 | 97.0% |
| Education | $72.84 | 5 | 3.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Sunovion Pharmaceuticals Inc. | $521.60 | 41 | $0 (2020) |
| Otsuka America Pharmaceutical, Inc. | $284.88 | 20 | $0 (2022) |
| Janssen Pharmaceuticals, Inc | $274.28 | 23 | $0 (2022) |
| Alkermes, Inc. | $254.97 | 15 | $0 (2022) |
| Allergan, Inc. | $246.32 | 8 | $0 (2020) |
| Vanda Pharmaceuticals Inc. | $211.92 | 13 | $0 (2022) |
| ABBVIE INC. | $192.99 | 11 | $0 (2023) |
| ITI, Inc. | $127.42 | 3 | $0 (2022) |
| Merck Sharp & Dohme Corporation | $97.34 | 1 | $0 (2017) |
| Lundbeck LLC | $77.50 | 6 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $55.26 | 3 | ABBVIE INC. ($55.26) |
| 2022 | $400.76 | 23 | ABBVIE INC. ($125.69) |
| 2021 | $27.89 | 2 | Otsuka America Pharmaceutical, Inc. ($15.85) |
| 2020 | $209.96 | 9 | ITI, Inc. ($98.12) |
| 2019 | $495.09 | 31 | Allergan Inc. ($142.11) |
| 2018 | $644.51 | 47 | Sunovion Pharmaceuticals Inc. ($299.28) |
| 2017 | $575.54 | 36 | Sunovion Pharmaceuticals Inc. ($124.21) |
All Payment Transactions
151 individual payment records from CMS Open Payments — Page 1 of 7
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 02/16/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $17.70 | General |
| Category: NEUROSCIENCE | ||||||
| 02/01/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $22.49 | General |
| Category: NEUROSCIENCE | ||||||
| 01/11/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $15.07 | General |
| Category: NEUROSCIENCE | ||||||
| 11/09/2022 | ABBVIE INC. | — | Food and Beverage | In-kind items and services | $24.89 | General |
| 11/03/2022 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug) | Food and Beverage | In-kind items and services | $18.51 | General |
| Category: Neuroscience | ||||||
| 09/28/2022 | ABBVIE INC. | — | Food and Beverage | In-kind items and services | $24.23 | General |
| 09/28/2022 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug), ABILIFY MAINTENA | Food and Beverage | In-kind items and services | $12.90 | General |
| Category: PSYCHIATRY | ||||||
| 08/18/2022 | ITI, Inc. | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $13.47 | General |
| Category: PSYCHIATRY | ||||||
| 08/12/2022 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA INITIO | Food and Beverage | In-kind items and services | $24.70 | General |
| Category: CNS | ||||||
| 08/10/2022 | ABBVIE INC. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $13.39 | General |
| Category: VIROLOGY | ||||||
| 07/28/2022 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug), ABILIFY MAINTENA | Food and Beverage | In-kind items and services | $15.34 | General |
| Category: PSYCHIATRY | ||||||
| 06/29/2022 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA INITIO | Food and Beverage | In-kind items and services | $24.39 | General |
| Category: CNS | ||||||
| 06/24/2022 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug), ABILIFY MAINTENA | Food and Beverage | In-kind items and services | $15.98 | General |
| Category: PSYCHIATRY | ||||||
| 06/22/2022 | Indivior Inc. | PERSERIS (Drug) | Food and Beverage | In-kind items and services | $12.75 | General |
| Category: BH | ||||||
| 06/15/2022 | ITI, Inc. | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $15.83 | General |
| Category: PSYCHIATRY | ||||||
| 06/08/2022 | Vanda Pharmaceuticals Inc. | HETLIOZ (Drug), FANAPT | Food and Beverage | In-kind items and services | $25.37 | General |
| Category: NON-24-HOUR SLEEP-WAKE DISORDER | ||||||
| 06/02/2022 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $27.76 | General |
| Category: NEUROSCIENCE | ||||||
| 05/18/2022 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug), ABILIFY MAINTENA | Food and Beverage | In-kind items and services | $13.95 | General |
| Category: PSYCHIATRY | ||||||
| 05/11/2022 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA INITIO | Food and Beverage | In-kind items and services | $18.28 | General |
| Category: CNS | ||||||
| 05/04/2022 | Vanda Pharmaceuticals Inc. | HETLIOZ (Drug), FANAPT | Food and Beverage | In-kind items and services | $19.96 | General |
| Category: NON-24-HOUR SLEEP-WAKE DISORDER | ||||||
| 05/03/2022 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $12.76 | General |
| Category: NEUROSCIENCE | ||||||
| 04/27/2022 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA INITIO | Food and Beverage | In-kind items and services | $17.51 | General |
| Category: CNS | ||||||
| 04/21/2022 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug) | Food and Beverage | In-kind items and services | $12.06 | General |
| Category: Neuroscience | ||||||
| 04/14/2022 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA INITIO | Food and Beverage | In-kind items and services | $14.07 | General |
| Category: CNS | ||||||
| 04/13/2022 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $9.95 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2021 | 1 | 16 | 24 | $4,527 | $1,252 |
| 2020 | 3 | 79 | 126 | $20,186 | $7,259 |
All Medicare Procedures & Services
4 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Office | 2021 | 16 | 24 | $4,527 | $1,252 | 27.7% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Office | 2020 | 27 | 49 | $8,231 | $3,694 | 44.9% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 31 | 48 | $8,247 | $2,582 | 31.3% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 21 | 29 | $3,708 | $983.10 | 26.5% |
About Dr. Almas Rahman, M.D
Dr. Almas Rahman, M.D is a Psychiatry healthcare provider based in Wentzville, Missouri. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/06/2006. The National Provider Identifier (NPI) number assigned to this provider is 1588723738.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Almas Rahman, M.D has received a total of $2,409 in payments from pharmaceutical and medical device companies, with $55.26 received in 2023. These payments were reported across 151 transactions from 13 companies. The most common payment nature is "Food and Beverage" ($2,336).
As a Medicare-enrolled provider, Rahman has provided services to 95 Medicare beneficiaries, totaling 150 services with total Medicare billing of $8,511. Data is available for 2 years (2020–2021), covering 4 distinct procedure/service records.
Practice Information
- Specialty Psychiatry
- Location Wentzville, MO
- Active Since 12/06/2006
- Last Updated 03/25/2019
- Taxonomy Code 2084P0800X
- Entity Type Individual
- NPI Number 1588723738
Products in Payments
- LATUDA (Drug) $521.60
- VRAYLAR (Drug) $376.80
- INVEGA SUSTENNA (Drug) $215.75
- REXULTI (Drug) $193.23
- ABILIFY MAINTENA (Drug) $169.15
- Fanapt (Drug) $166.59
- Aristada 441 mg (Drug) $141.49
- CAPLYTA (Drug) $127.42
- ARISTADA (Drug) $113.48
- BELSOMRA (Drug) $97.34
- Trintellix (Drug) $62.61
- INVEGA TRINZA (Drug) $47.50
- HETLIOZ (Drug) $45.33
- INGREZZA (Drug) $30.49
- TRINTELLIX (Drug) $13.94
- MAVYRET (Drug) $13.39
- PERSERIS (Drug) $12.75
- SPRAVATO (Drug) $11.03
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Psychiatry Doctors in Wentzville
Dr. Harmeeta Singh, M.d, M.D
Psychiatry — Payments: $16,286
David Goldmeier, M.d, M.D
Psychiatry — Payments: $6,573
James Byrd, D.o, D.O
Psychiatry — Payments: $4,597
Fernando Perez-Magnelli, Md, MD
Psychiatry — Payments: $2,539
Dr. Gopinath Gorthy, Md, MD
Psychiatry — Payments: $893.51
Pappa Ehimare, Md, MD
Psychiatry — Payments: $844.20